TITLE

Hepatitis C Virus Infection-Related Morbidity and Mortality among Patients with Human Immunodeficiency Virus Infection

AUTHOR(S)
Monga, Harpreet K.; Rodriguez-Barradas, Maria C.; Breaux, Katharine; Khattak, Kamran; Troisi, Catherine L.; Velez, Maria; Yoffe, Boris
PUB. DATE
July 2001
SOURCE
Clinical Infectious Diseases;7/15/2001, Vol. 33 Issue 2, p240
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Presents a study that discussed the morbidity and mortality of Hepatitis C virus (HCV) infection among patients with HIV virus infection. Factors that might promote progression of HCV-related chronic liver disease and HIV disease; Demographic characteristics, seroprevalence and baseline assessment of HCV and HIV; Background of HIV epidemic.
ACCESSION #
4853750

 

Related Articles

  • Screening for infectious diseases in newly arrived asymptomatic immigrants in southern Italy. Scotto, Gaetano; Fazio, Vincenzina; Muzio, Lorenzo Lo; Coppola, Nicola // Eastern Mediterranean Health Journal;Apr2019, Vol. 25 Issue 4, p246 

    Background: Screenings for infectious diseases in asymptomatic immigrants currently takes place when receiving new arrivals. Aims: We describe the frequency of infections in a cohort of newly arrived asymptomatic immigrants in Southern Italy. Methods: We studied a cohort of 238 Sub-Saharan...

  • Prediction of Response to Pegylated Interferon plus Ribavirin by IL28B Gene Variation in Patients Coinfected with HIV and Hepatitis C Virus. Pneda, Juan A.; Caruz, Antonio; Rivero, Antonio; Neukam, Karin; Salas, Irene; Camacho, Ángela; Palomares, José C.; Mira, José A.; Martínez, Antonio; Roldán, Carmen; de la Torre, Julián; Juan Macías // Clinical Infectious Diseases;10/1/2010, Vol. 51 Issue 7, p788 

    Background. Variation in the IL28B gene is associated with sustained virologic response (SVR) to pegylated interferon plus ribavirin in hepatitis C virus (HCV)-monoinfected patients with genotype 1. Data on other genotypes and on patients coinfected with human immunodeficiency virus (HIV) and...

  • Norjizak Injection: A Critical Risk for Transmitting Blood-Borne Infectious Diseases. Mehrjerdi, Zahra Alam // Hepatitis Monthly;Apr2013, Vol. 13 Issue 4, p1 

    A letter to the editor is presented in response to the article in the previous issue relatred with infectious diseases.

  • IN BRIEF.  // Nursing Standard;11/15/2006, Vol. 21 Issue 10, p6 

    The article offers news brief related to National Health Services (NHS) staff management. It is inferred that nurses joining the NHS face human immunodeficiency virus and Hepatitis C test if nurses carry out invasive procedures. The governing council of Royal College of Nursing (RCN) is to write...

  • Hepatitis C.  // GP: General Practitioner;4/14/2014, p36 

    The article reports on data published in the "Journal of Viral Hepatitis" in April 2014 on the number of lives to be saved and liver transplants to be prevented in England from tripling diagnosis and treatment rates for hepatitis C, according to the Hepatitis C Trust.

  • Hepatitis: A Rapidly Spreading Viral Infection in Pakistan. MENHAS, Rashid; UMER, Shumaila // Iranian Journal of Public Health;Jun2015, Vol. 44 Issue 6, p879 

    A letter to the editor is presented which discusses the spread of hepatitis C virus (HCV) infection in Pakistan.

  • Viral disease tests: A changing arena. Lewis, Laurie; Gruber, William // Patient Care;2/28/1999, Vol. 33 Issue 4, p18 

    Reports on the availability of improved serology and molecular techniques for earlier diagnosis of viral infections. Quicker, safer, cost-effective laboratory methods; Diagnostic tests for hepatitis C, HIV, herpes infections, respiratory infections; Advantages offered by the diagnostic techniques.

  • Early hepatitis C RNA testing is most cost effective strategy.  // Nursing Standard;2/18/2009, Vol. 23 Issue 24, p16 

    The article reports that researchers in France have found that a strategy based on early hepatitis C RNA testing shortens the time healthcare workers exposed to the hepatitis C virus must wait for the results of their virus status, is reasonably cost effective, and results in a lower risk of...

  • Testing for HCV Infection: An Update of Guidance for Clinicians and Laboratorians. Getchell, Jane P.; Wroblewski, Kelly E.; DeMaria Jr., Alfred; Bean, Christine L.; Parker, Monica M.; Pandori, Mark; Dufour, D. Robert; Busch, Michael P.; Brecher, Mark E.; Meyer, William A.; Pesano, Rick L.; Chong-Gee Teo; Beckett, Geoffrey A.; Araujo, Aufra C.; Branson, Bernard M.; Drobeniuc, Jan; Hatia, Rikita; Holmberg, Scott D.; Kamili, Saleem; Ward, John W. // MMWR: Morbidity & Mortality Weekly Report;5/10/2013, Vol. 62 Issue 18, p362 

    The article presents an update of guidance for clinicians and laboratorians for hepatitis C virus (HCV) testing. It enumerates changes in HCV testing technologies, including the availability of a rapid test for HCV antibody. The article also cites the benefits of testing for current HCV...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics